School of Medicine
Showing 1-10 of 35 Results
-
Neal Amin
Resident in Psychiatry and Behavioral Sciences
Bio Neal D. Amin, MD, PhD received his bachelors in Biochemistry from Columbia University where he studied the structure-function relationship of neurexins and neuroligins, proteins implicated in familial autism. He continued his research interests as a medical and doctoral student at the University of California, San Diego in the Medical Scientist Training Program (MD/PhD). Dr. Amin's doctoral research was conducted at the Salk Institute for Biological Studies in the laboratory of Howard Hughes Medical Investigator Samuel Pfaff, where he studied spinal cord development and neurodegenerative disease. He used transcriptomics, mouse genetics, and deep phenotyping to uncover novel gene regulatory pathways driving the establishment of neuronal identity and function. Dr. Amin is currently a resident physician in the research track in the Department of Psychiatry and Behavioral Sciences at Stanford University with a particular interest in neurobiology and understanding molecular mechanisms behind neuropsychiatric disease.
-
Brandon Bentzley
Resident in Psychiatry and Behavioral Sciences
Bio Brandon received his bachelors in physics from The College of New Jersey. Upon graduating he spent a year conducting plasma physics research in a joint project between Princeton University and NASA. Brandon then turned his interests to addiction neuroscience and began his training in the Medical Scientist Training Program (MD/PhD) at the Medical University of South Carolina (MUSC). At MUSC Brandon completed his dissertation research with Gary Aston-Jones, PhD, studying the behavioral economics and neuroeconomics of drug self-administration in rats. Simultaneously, Brandon conducted clinical research on buprenorphine maintenance therapy, focusing on how patient perspectives influence treatment. Brandon is currently a resident physician in the research track in the Department of Psychiatry and Behavioral Sciences at Stanford. Brandon's current research interests focus on developing neurostimulation-based treatments for substance use disorders within a neuroeconomic framework.
